Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 3Recruiting 2Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Recurrence 1Carcinoma, Basal Cell 1

Interventions

Specimen Handling 12Magnetic Resonance Spectroscopy 10Cyclophosphamide 10Cisplatin 7Bevacizumab 7pembrolizumab 6Radiosurgery 6Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5Biopsy 5venetoclax 4fludarabine 4S 1 (combination) 4Prednisone 4Leucovorin 4Gemcitabine 4Etoposide 4Drug Therapy 4Doxorubicin 4Azacitidine 4fludarabine phosphate 3Vincristine 3Taxes 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × OTHER × Curettage × Clear all
NCT00515970 2010-06-15

Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas

University Hospital Tuebingen

Phase NA Suspended
400 enrolled
Dermatologic

Carcinoma, Basal Cell, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡